India Bulk Drug Makers Start Preparing for Ozempic Patent Expiry
PositiveFinancial Markets

Indian pharmaceutical companies are gearing up to produce active pharmaceutical ingredients for weight-loss drugs as Novo Nordisk's Ozempic faces patent expiry next year. This is significant because it opens the door for more affordable alternatives in the market, potentially benefiting many consumers looking for weight-loss solutions.
— Curated by the World Pulse Now AI Editorial System